Detailed information for compound 1868821

Basic information

Technical information
  • TDR Targets ID: 1868821
  • Name: 4-Methyl-2,6-dinitrophenol
  • MW: 198.133 | Formula: C7H6N2O5
  • H donors: 1 H acceptors: 5 LogP: 2.14 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: Cc1cc([N+](=O)[O-])c(c(c1)[N+](=O)[O-])O
  • InChi: 1S/C7H6N2O5/c1-4-2-5(8(11)12)7(10)6(3-4)9(13)14/h2-3,10H,1H3
  • InChiKey: HOYRZHJJAHRMLL-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 4-methyl-2,6-dinitro-phenol
  • 609-93-8
  • ST5308371
  • 2,6-Dinitro-4-methylphenol
  • 2,6-Dinitro-p-cresol
  • DNPC
  • Dinitro-p-cresol
  • NSC33870
  • Phenol, 4-methyl-2,6-dinitro-
  • Victoria Orange
  • Victoria Yellow
  • WLN: WNR BQ E1 CNW
  • 42115_FLUKA
  • 227536_ALDRICH
  • 3,5-Dinitro-4-hydroxytoluene
  • 4-06-00-02152 (Beilstein Handbook Reference)
  • AI3-24606
  • BRN 1978786
  • EINECS 210-203-8
  • HSDB 5434
  • NSC 33870
  • Toluene, 3,5-dinitro-4-hydroxy-
  • InChI=1/C7H6N2O5/c1-4-2-5(8(11)12)7(10)6(3-4)9(13)14/h2-3,10H,1H
  • p-Cresol, 2,6-dinitro-

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens nuclear factor, erythroid 2-like 2 Starlite/ChEMBL No references
Homo sapiens G protein-coupled receptor 35 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Entamoeba histolytica hypothetical protein 0.0043 0.5 0.5
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription 0.0043 0.5 0.5
Entamoeba histolytica hypothetical protein 0.0043 0.5 0.5
Schistosoma mansoni hypothetical protein 0.0043 0.5 0.5
Schistosoma mansoni transcription factor LCR-F1 0.0043 0.5 0.5
Echinococcus granulosus Basic leucine zipper bZIP transcription 0.0043 0.5 0.5
Entamoeba histolytica hypothetical protein 0.0043 0.5 0.5
Entamoeba histolytica hypothetical protein 0.0043 0.5 0.5

Activities

Activity type Activity value Assay description Source Reference
Activity (binding) Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation at 64 uM after 5 hrs by beta-lactamase reporter gene assay in presence of GPR35 antagonist ML-145 ChEMBL. No reference
Activity (binding) Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution at 32 uM after 50 mins by resonant waveguide grating biosensor analysis in presence of GPR35 antagonist ML-145 ChEMBL. No reference
Activity (binding) Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis ChEMBL. No reference
EC50 (binding) = 5.27 uM Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis ChEMBL. No reference
EC50 (binding) = 36.4 uM Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay ChEMBL. No reference
Efficacy (binding) = 83 % Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay relative to zaprinast ChEMBL. No reference
Efficacy (binding) = 235 pM Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis relative to control ChEMBL. No reference
Potency (functional) 9.7872 uM PubChem BioAssay: Tox21. qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 31.2247 uM PubChem BioAssay: Tox21. qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 39.3096 uM PubChem BioAssay: Tox21. qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 39.3096 uM PubChem BioAssay: Tox21. qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway. (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.